NO173331C - Analogifremgangsm}te for fremstilling av terapeutisk virksomme substituerte 1-(1H-imidazol-4-yl)-alkylbenzamider ogderes ikke-toksiske, for farmas!ytiske form}l akseptable syreaddisjonssalter - Google Patents

Analogifremgangsm}te for fremstilling av terapeutisk virksomme substituerte 1-(1H-imidazol-4-yl)-alkylbenzamider ogderes ikke-toksiske, for farmas!ytiske form}l akseptable syreaddisjonssalter

Info

Publication number
NO173331C
NO173331C NO891760A NO891760A NO173331C NO 173331 C NO173331 C NO 173331C NO 891760 A NO891760 A NO 891760A NO 891760 A NO891760 A NO 891760A NO 173331 C NO173331 C NO 173331C
Authority
NO
Norway
Prior art keywords
alkyl
imidazol
hydrogen
preparation
alkylbenzamides
Prior art date
Application number
NO891760A
Other languages
English (en)
Norwegian (no)
Other versions
NO173331B (no
NO891760L (no
NO891760D0 (no
Inventor
Eric Cossement
Jean-Pierre Geerts
Jean Gobert
Philippe Michel
Ernst Wuelfert
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of NO891760D0 publication Critical patent/NO891760D0/no
Publication of NO891760L publication Critical patent/NO891760L/no
Publication of NO173331B publication Critical patent/NO173331B/no
Publication of NO173331C publication Critical patent/NO173331C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Lubricants (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
NO891760A 1988-04-28 1989-04-27 Analogifremgangsm}te for fremstilling av terapeutisk virksomme substituerte 1-(1H-imidazol-4-yl)-alkylbenzamider ogderes ikke-toksiske, for farmas!ytiske form}l akseptable syreaddisjonssalter NO173331C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888810067A GB8810067D0 (en) 1988-04-28 1988-04-28 Substituted 1-(1h-imidazol-4-yl)alkyl-benzamides

Publications (4)

Publication Number Publication Date
NO891760D0 NO891760D0 (no) 1989-04-27
NO891760L NO891760L (no) 1989-10-30
NO173331B NO173331B (no) 1993-08-23
NO173331C true NO173331C (no) 1993-12-08

Family

ID=10636026

Family Applications (1)

Application Number Title Priority Date Filing Date
NO891760A NO173331C (no) 1988-04-28 1989-04-27 Analogifremgangsm}te for fremstilling av terapeutisk virksomme substituerte 1-(1H-imidazol-4-yl)-alkylbenzamider ogderes ikke-toksiske, for farmas!ytiske form}l akseptable syreaddisjonssalter

Country Status (30)

Country Link
US (1) US4923865A (ja)
EP (1) EP0341231B1 (ja)
JP (1) JP2840288B2 (ja)
KR (1) KR970011275B1 (ja)
AT (1) ATE82571T1 (ja)
AU (1) AU610796B2 (ja)
BR (2) BR1100052A (ja)
CA (1) CA1310966C (ja)
CY (1) CY1758A (ja)
DE (1) DE68903531T2 (ja)
DK (1) DK205589A (ja)
ES (1) ES2052969T3 (ja)
FI (1) FI101791B1 (ja)
GB (1) GB8810067D0 (ja)
GR (1) GR3006836T3 (ja)
HK (1) HK9494A (ja)
HU (1) HU203877B (ja)
IE (1) IE63698B1 (ja)
IL (1) IL90087A0 (ja)
LT (1) LT3671B (ja)
LV (1) LV10437B (ja)
MY (1) MY104084A (ja)
NO (1) NO173331C (ja)
NZ (1) NZ228897A (ja)
PH (1) PH25461A (ja)
PL (2) PL161362B1 (ja)
PT (1) PT90368B (ja)
RU (3) RU1830063C (ja)
UA (1) UA12835A1 (ja)
ZA (1) ZA893140B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310965D0 (en) * 1993-05-27 1993-07-14 Ucb Sa 2-hydroxy-3-(1h-imidazol-4-yl)alkyl)benzenecarboximidamides
ATE234290T1 (de) * 1993-11-15 2003-03-15 Schering Corp Phenylalkyl-imidazole als h3-rezeptor- antagonisten
JP3294961B2 (ja) * 1993-12-10 2002-06-24 杏林製薬株式会社 新規イミダゾール誘導体及びその製造法
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
DE10161818A1 (de) * 2001-12-14 2003-06-26 Gruenenthal Gmbh Substituierte 1,5-Diaminopentan-3-ol-Verbindungen
WO2006042150A1 (en) * 2004-10-07 2006-04-20 Vitae Pharmaceuticals, Inc. Diaminoalkane aspartic protease inhibitors
TWI411607B (zh) * 2005-11-14 2013-10-11 Vitae Pharmaceuticals Inc 天門冬胺酸蛋白酶抑制劑
CL2007002689A1 (es) 2006-09-18 2008-04-18 Vitae Pharmaceuticals Inc Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
EP2167609A1 (en) * 2007-06-20 2010-03-31 Vitae Pharmaceuticals, Inc. Renin inhibitors
EP2170815A2 (en) * 2007-06-20 2010-04-07 Vitae Pharmaceuticals, Inc. Renin inhibitors
US20090226549A1 (en) * 2008-03-06 2009-09-10 Kenneth John Hughes Herbal extracts and flavor systems for oral products and methods of making the same
CA2727987A1 (en) * 2008-06-20 2009-12-23 Vitae Pharmaceuticals, Inc. Renin inhibitors and method of use thereof
MX2010014557A (es) * 2008-06-26 2011-02-15 Vitae Pharmaceuticals Inc Sales de 2-((r)-(3-clorofenil)((r)-1-((s)-2-(metilamino)-3-((r)-te trahidro-2h-piran-3-il)propilcarbamoil)piperidin-3-il)metoxi)etil carbamato de metilo.
AR077692A1 (es) * 2009-08-06 2011-09-14 Vitae Pharmaceuticals Inc Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
AU2012212323A1 (en) * 2011-02-01 2013-09-12 The Board Of Trustees Of The University Of Illinois HDAC inhibitors and therapeutic methods using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
US4303485A (en) 1979-08-20 1981-12-01 Minnesota Mining And Manufacturing Company Ultraviolet polymerization of acrylate monomers using oxidizable tin compounds
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
DE3635700A1 (de) 1986-10-21 1988-04-28 Michael Schmeller Hubeinrichtung
GB8626287D0 (en) * 1986-11-04 1986-12-03 Ucb Sa Substituted 1h-imidazoles
GB8714013D0 (en) * 1987-06-16 1987-07-22 Ici Plc (substituted-aralkyl)heterocyclic compounds

Also Published As

Publication number Publication date
FI101791B (fi) 1998-08-31
BR1100052A (pt) 1999-12-07
FI891975A (fi) 1989-10-29
CY1758A (en) 1994-07-15
GR3006836T3 (ja) 1993-06-30
NZ228897A (en) 1990-08-28
DE68903531D1 (de) 1992-12-24
DK205589D0 (da) 1989-04-27
IL90087A0 (en) 1989-12-15
RU1830063C (ru) 1993-07-23
LT3671B (en) 1996-01-25
AU610796B2 (en) 1991-05-23
PL161362B1 (pl) 1993-06-30
EP0341231A1 (fr) 1989-11-08
ES2052969T3 (es) 1994-07-16
FI891975A0 (fi) 1989-04-26
KR890016017A (ko) 1989-11-28
LV10437B (en) 1996-04-20
CA1310966C (en) 1992-12-01
AU3373089A (en) 1989-11-02
IE63698B1 (en) 1995-05-31
PH25461A (en) 1991-07-01
FI101791B1 (fi) 1998-08-31
RU1814647C (ru) 1993-05-07
JPH01313467A (ja) 1989-12-18
NO173331B (no) 1993-08-23
MY104084A (en) 1993-11-30
UA12835A1 (uk) 1997-02-28
ATE82571T1 (de) 1992-12-15
NO891760L (no) 1989-10-30
KR970011275B1 (ko) 1997-07-09
PL156250B1 (pl) 1992-02-28
PT90368A (pt) 1989-11-10
GB8810067D0 (en) 1988-06-02
US4923865A (en) 1990-05-08
JP2840288B2 (ja) 1998-12-24
NO891760D0 (no) 1989-04-27
LV10437A (lv) 1995-02-20
EP0341231B1 (fr) 1992-11-19
HU203877B (en) 1991-10-28
HUT51257A (en) 1990-04-28
IE891360L (en) 1989-10-28
HK9494A (en) 1994-02-09
LTIP827A (en) 1995-02-27
DE68903531T2 (de) 1993-04-29
ZA893140B (en) 1990-01-31
BR1100064A (pt) 1999-12-07
RU1836353C (ru) 1993-08-23
PT90368B (pt) 1994-08-31
DK205589A (da) 1989-10-29

Similar Documents

Publication Publication Date Title
NO173331C (no) Analogifremgangsm}te for fremstilling av terapeutisk virksomme substituerte 1-(1H-imidazol-4-yl)-alkylbenzamider ogderes ikke-toksiske, for farmas!ytiske form}l akseptable syreaddisjonssalter
ES8603408A1 (es) Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida
IL126969A (en) 2,4-diaminopyrimidine derivatives, a process for their preparation, their use for the preparation of dopamine d4 antagonist pharmaceutical compositions and their use in labeling dopamine d4 receptor
ES8402559A1 (es) Un procedimiento para preparar nuevos compuestos peptidicos.
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
YU182581A (en) Process for preparing new 5,10-dihydro-11h-dibenzo-(b,e)(1,4)diazepine-11-ones substituted in position 5
IE822330L (en) 2,2-disubstituted-ethylamines
DE3363312D1 (en) Process for preparing (3s)-3-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)-acetyl)amino)-2-oxo-1-azetidinesulfonic acid and 4-substituted derivatives
ES2000907A6 (es) Procedimiento de preparar compuestos 2-oxaisocefen microbiologicamente activos
CA2093510A1 (en) Oxysulfonyl carbamates
ES8403866A1 (es) Un metodo de producir un derivado de 4-ciano-2-azetidinona.
ES8706156A1 (es) Un procedimiento para la preparacion de compuestos de cefa- losporina
AU1012988A (en) New N-(1H-indol-4-yl)benzamide derivatives and also their salts, their application by way of medicinal products and the compositions containing them
GB1411782A (en) Piperidine derivatives
ES2100125A1 (es) Procedimiento de preparacion de esteres de matanodiol de acido dioxopeneicilanico.
ES8600206A1 (es) Procedimiento de preparacion de derivados alquilenodiaminos

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2001